FOXO Technologies (FOXOW) said on Wednesday its subsidiary, Vector BioSource, entered into a definitive agreement to acquire four U.S. blood collection centers from Grifols Bio Supplies. – The asset purchase is expected to close in the third or fourth quarter of 2026, subject to…
gulatory approvals, including required FDA licensure. – FOXO said the acquisition is expected to add more than $10M in net revenue over the 12 months following closing, based on historical information and management estimates. More on FOXO Technologies